The first utility-oriented, agnostic software platform for quantum-centric drug discoverybroad
KvasirAccelerator · Horizon Europe grant · 2023-08-01–2025-07-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2023-ACCELERATOR-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2023-ACCELERATOROPEN-01. CORDIS record →
Objective
Humanity is exploring the limits of computing to solve the world’s biggest challenges with unprecedented speed and precision. While quantum hardware is being matured into a commercial technology, there is still no quantum software capable of addressing real business problems. Furthermore, quantum computing will inevitably exacerbate the complexity of current computational workflows for non-coding experts to extract knowledge. At Kvantify, we are developing Kvaser, the first platform-agnostic, explainable, customer-centric quantum software tool, to be operated by the end-user. With EIC funding, we will develop advanced algorithms for quantum chemistry and machine learning that will solve real-life drug R&D problems beyond the scope of classical resources. Kvaser will empower R&D scientists to run molecular and biochemical simulations on modern hardware with unmatched speed and accuracy, enabling high precision quantum chemistry calculations for efficient and accelerated drug discovery.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| KVANTIFY APS | DK | coordinator | €2,499,999 | Yes |
Get the EU Defence Funding Calendar — free
The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.
Or browse all open defence & dual-use calls on the funding calendar →
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.